Company / Total Assets
TherapeuticsMD, Inc. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$38.8M
FY2024
5-year range
$38.8M / $181.6M
FY2020-FY2024
Trend
-10.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 5 consecutive years, from $266M in FY2019 to $39M in FY2024.
Based on SEC 10-K filings.
$39M in FY2024 with a 5-year CAGR of -31.9%.
Declined from $90M to $39M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -38.8%
- 5-Year CAGR
- -31.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- TherapeuticsMD, Inc.'s total assets has declined for 5 consecutive years.
- 5-year CAGR of -31.9%, indicating a declining trend.
- In FY2024, total assets decreased 10.4% year-over-year.
- Peak total assets was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $38.8M | -10.4% |
| FY2023 | $43.3M | -52.1% |
| FY2022 | $90.5M | -46.6% |
| FY2021 | $169.5M | -6.7% |
| FY2020 | $181.6M | -31.7% |
| FY2019 | $266.0M | +25.5% |
| FY2018 | $212.0M | +48.0% |
| FY2017 | $143.2M | +0.5% |
| FY2016 | $142.5M | +93.2% |
| FY2015 | $73.7M | +24.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026